ID   KP 1
AC   CVCL_A1IF
DR   Wikidata; Q102114429
RX   PubMed=758928;
RX   PubMed=7200272;
CC   Population: Japanese.
CC   Doubling time: 45 hours (PubMed=7200272).
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
RX   PubMed=758928; DOI=10.1038/bjc.1979.3; PMCID=PMC2009802;
RA   Kinjo, Mitsuru
RA   Oka, Kazunari
RA   Naito, S.
RA   Kohga, Shin
RA   Tanaka, Kenzo
RA   Oboshi, Shoichi
RA   Hayata, Yoshihiro
RA   Yasumoto, Kosei
RT   "Thromboplastic and fibrinolytic activities of cultured human cancer
RT   cell lines.";
RL   Br. J. Cancer 39:15-23(1979).
//
RX   PubMed=7200272; DOI=10.1007/BF00256519;
RA   Naito, Seiji
RA   Tanaka, Kenzo
RA   Kanamori, Toshinori
RA   Hisano, Shusuke
RA   Momose, Shunro
RT   "Establishment of a human renal pelvic cancer cell line producing
RT   tissue thromboplastin and plasminogen activator.";
RL   Urol. Res. 10:19-25(1982).
//